14. Sept. 2026•3 Min. Lesezeit
MHRA withdraws UK marketing authorisation for Tavneos (avacopan)
The UK MHRA has decided to withdraw the marketing authorisation for Tavneos (avacopan) for ANCA-associated vasculitis, halting new patient supply from 1 Sept.